Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Waltermire Robert E. - Insider Transactions

Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week Filter
Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 15Option Exercise87.922,000175,8407,667Dec 18 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 14Option Exercise87.922,000175,8407,667Dec 18 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 14Sale232.502,000465,0005,667Dec 18 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 15Sale238.502,000477,0005,667Dec 18 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 12Option Exercise87.921,300114,2966,967Dec 14 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 13Option Exercise87.922,500219,8008,167Dec 14 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 13Sale225.402,500563,5005,667Dec 14 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Dec 12Sale217.851,300283,2005,667Dec 14 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Feb 28Option Exercise87.925,000439,60010,667Mar 02 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Mar 01Option Exercise87.925,000439,60010,667Mar 02 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Mar 01Sale274.425,0001,372,0815,667Mar 02 04:30 PM
MDGLWaltermire Robert E.Senior VP, Chief Pharma Dev.Feb 28Sale272.075,0001,360,3575,667Mar 02 04:30 PM
open in screener

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.